Skip to main content
. 2021 May 31;64(9):1973–1981. doi: 10.1007/s00125-021-05485-5

Table 1.

Descriptive statistics for the total population and for four clusters

Variable Total population (N = 114,231) Cluster 1 (n = 12,133) Cluster 2 (n = 27,888) Cluster 3 (n = 41,555) Cluster 4 (n = 32,825)
Sex, female 43.1 32.0 44.5 49.5 38.0
Age at diagnosis, years 62.8 ± 12.78 57.0 ± 11.68 65.4 ± 9.70 71.5 ± 9.01 51.8 ± 9.99
BMI, kg/m2 30.5 ± 5.65 31.6 ± 5.97 30.8 ± 5.19 28.0 ± 4.26 32.9 ± 6.17
HbA1c, mmol/mol 54.3 ± 17.10 89.5 ± 21.12 50.9 ± 10.88 49.0 ± 10.09 50.9 ± 10.48
HbA1c, % 7.1 10.3 6.8 6.6 6.8
Systolic BP, mmHg 137.2 ± 17.37 137.8 ± 15.98 155.8 ± 14.88 132.0 ± 13.07 127.9 ± 11.69
Diastolic BP, mmHg 79.6 ± 10.04 82.9 ± 9.60 88.6 ± 8.20 73.3 ± 7.69 78.7 ± 7.82
Triacylglycerol, mmol/l 2.0 ± 1.33 3.8 ± 2.55 1.8 ± 0.90 1.6 ± 0.78 2.0 ± 0.98
HDL-cholesterol, mmol/l 1.2 ± 0.38 1.0 ± 0.28 1.3 ± 0.35 1.4 ± 0.43 1.1 ± 0.27
LDL-cholesterol, mmol/l 3.1 ± 1.00 3.5 ± 1.08 3.4 ± 0.99 2.8 ± 0.92 3.1 ± 0.94
eGFR, ml min−1 [1.73 m]−2 84.8 ± 24.57 97.1 ± 26.99 80.7 ± 19.85 71.9 ± 18.35 100.0 ± 23.69
Country of birth
 Sweden 80.1 77.1 72.5 82.9 85.5
 Nordic countries (excl. Sweden) 5.3 4.9 4.4 6.3 5.5
 Europe (excl. EU27 & Nordic countries) 3.0 3.7 4.0 2.9 2.2
 EU27 (excl. Nordic countries) 2.5 2.4 2.3 2.7 2.7
 Mediterranean countries 0.4 0.5 0.5 0.4 0.4
 Middle East 4.5 5.6 8.8 2.7 1.9
 Asia 1.5 2.2 2.9 0.6 0.7
 South America 0.7 1.0 1.1 0.5 0.4
 North America & Oceania 0.2 0.3 0.4 0.2 0.1
 Africa 1.6 2.5 3.0 0.8 0.5

Data are means ± SD or percentages

Clinical characteristics for the NDR population as a total and divided into four clusters

The cluster analysis is based on the k-means algorithm using imputed and normalised observations on age, BMI, HbA1c, systolic BP, diastolic BP, triacylglycerol, HDL-cholesterol, LDL-cholesterol and eGFR from individuals with newly diagnosed type 2 diabetes

The regions represent countries of birth grouped in larger areas